Location: San Francisco, CA
CIK: 0000909661 · Show all filings
Period: Q3 2018 (← Previous) (Next →)
Filing Date: Nov 14, 2018
Total Value: $16.93B (99.8% shares, 0.2% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TR | 9,290,500 | $2.701B | 16.0% | $290.72 | — | — | Put | 78462F103 |
| — | AETNA INC NEW | 7,425,000 | $1.506B | 8.9% | $202.85 | — | — | COM | 00817Y108 |
| — | ALTABA INC | 21,237,317 | $1.447B | 8.5% | $68.12 | — | — | COM | 021346101 |
| — | EXPRESS SCRIPTS HLDG CO | 11,895,000 | $1.13B | 6.7% | $95.01 | — | — | COM | 30219G108 |
| — | DELL TECHNOLOGIES INC | 6,389,000 | $621M | 3.7% | $97.12 | — | — | COM CL V | 24703L103 |
| — | ROCKWELL COLLINS INC | 4,155,000 | $584M | 3.4% | $140.47 | — | — | COM | 774341101 |
| META | FACEBOOK INC | 2,485,943 | $409M | 2.4% | $164.46 | — | — | CL A | 30303M102 |
| IQV | IQVIA HLDGS INC | 3,039,386 | $394M | 2.3% | $129.74 | — | — | COM | 46266C105 |
| CHTR | CHARTER COMMUNICATIONS INC N | 1,182,980 | $386M | 2.3% | $325.88 | — | — | CL A | 16119P108 |
| GOOG | ALPHABET INC | 314,705 | $376M | 2.2% | $1193.47 | — | — | CAP STK CL C | 02079K107 |
| WAB | WABTEC CORP | 3,500,600 | $367M | 2.2% | $104.88 | — | — | COM | 929740108 |
| GD | GENERAL DYNAMICS CORP | 1,770,722 | $363M | 2.1% | $204.72 | — | — | COM | 369550108 |
| V | VISA INC | 1,973,191 | $296M | 1.7% | $150.09 | — | — | COM CL A | 92826C839 |
| — | PLAYA HOTELS & RESORTS NV | 30,606,930 | $295M | 1.7% | $9.63 | — | — | SHS | N70544106 |
| — | TILRAY INC | 2,479,515 | $285M | 1.7% | $115.14 | — | — | COM CL 2 | 88688T100 |
| ELV | ANTHEM INC | 1,035,000 | $284M | 1.7% | $274.05 | — | — | COM | 036752103 |
| — | IHS MARKIT LTD | 5,055,245 | $273M | 1.6% | $53.96 | — | — | SHS | G47567105 |
| EQIX | EQUINIX INC | 608,600 | $263M | 1.6% | $432.89 | — | — | COM PAR $0.001 | 29444U700 |
| — | ENVISION HEALTHCARE CORP | 5,615,000 | $257M | 1.5% | $45.73 | — | — | COM | 29414D100 |
| BKNG | BOOKING HLDGS INC | 128,270 | $254M | 1.5% | $1984.00 | — | — | COM | 09857L108 |
| TRU | TRANSUNION | 3,427,611 | $252M | 1.5% | $73.58 | — | — | COM | 89400J107 |
| MSFT | MICROSOFT CORP | 2,159,213 | $247M | 1.5% | $114.37 | — | — | COM | 594918104 |
| — | TWENTY FIRST CENTY FOX INC | 5,360,000 | $246M | 1.5% | $45.82 | — | — | CL B | 90130A200 |
| FIS | FIDELITY NATL INFORMATION SV | 1,961,994 | $214M | 1.3% | $109.07 | — | — | COM | 31620M106 |
| — | CITRIX SYS INC | 1,812,849 | $202M | 1.2% | $111.16 | — | — | COM | 177376100 |
| — | LIBERTY GLOBAL PLC | 6,991,640 | $197M | 1.2% | $28.16 | — | — | SHS CL C | G5480U120 |
| LBTYAUSD | LIBERTY GLOBAL PLC | 6,629,602 | $192M | 1.1% | $28.93 | — | — | SHS CL A | G5480U104 |
| VRSK | VERISK ANALYTICS INC | 1,424,553 | $172M | 1.0% | $120.55 | — | — | COM | 92345Y106 |
| — | BROOKFIELD PROPERTY REIT INC | 8,054,215 | $169M | 1.0% | $20.93 | — | — | CL A | 11282X103 |
| NXPI | NXP SEMICONDUCTORS N V | 1,650,000 | $141M | 0.8% | $85.50 | — | — | COM | N6596X109 |
| AZN | ASTRAZENECA PLC | 3,420,000 | $135M | 0.8% | $39.57 | — | — | SPONSORED ADR | 046353108 |
| EFX | EQUIFAX INC | 815,817 | $107M | 0.6% | $130.57 | — | — | COM | 294429105 |
| — | ACCELERON PHARMA INC | 1,840,732 | $105M | 0.6% | $57.23 | — | — | COM | 00434H108 |
| ASND | ASCENDIS PHARMA A S | 1,457,297 | $103M | 0.6% | $70.86 | — | — | SPONSORED ADR | 04351P101 |
| — | MYOKARDIA INC | 1,531,278 | $99.84M | 0.6% | $65.20 | — | — | COM | 62857M105 |
| — | ZOGENIX INC | 1,795,500 | $89.06M | 0.5% | $49.60 | — | — | COM NEW | 98978L204 |
| — | SAGE THERAPEUTICS INC | 625,000 | $88.28M | 0.5% | $141.25 | — | — | COM | 78667J108 |
| — | FIBROGEN INC | 1,395,000 | $84.75M | 0.5% | $60.75 | — | — | COM | 31572Q808 |
| — | SINA CORP | 1,124,224 | $78.11M | 0.5% | $69.48 | — | — | ORD | G81477104 |
| — | ARRAY BIOPHARMA INC | 5,125,000 | $77.9M | 0.5% | $15.20 | — | — | COM | 04269X105 |
| AVA | AVISTA CORP | 1,470,000 | $74.32M | 0.4% | $50.56 | — | — | COM | 05379B107 |
| ENTA | ENANTA PHARMACEUTICALS INC | 867,500 | $74.14M | 0.4% | $85.46 | — | — | COM | 29251M106 |
| NVCR | NOVOCURE LTD | 1,350,000 | $70.74M | 0.4% | $52.40 | — | — | ORD SHS | G6674U108 |
| — | TWENTY FIRST CENTY FOX INC | 1,435,000 | $66.48M | 0.4% | $46.33 | — | — | CL A | 90130A101 |
| BABA | ALIBABA GROUP HLDG LTD | 373,000 | $61.45M | 0.4% | $164.76 | — | — | SPONSORED ADS | 01609W102 |
| — | CA INC | 1,382,361 | $61.03M | 0.4% | $44.15 | — | — | COM | 12673P105 |
| — | REATA PHARMACEUTICALS INC | 673,500 | $55.06M | 0.3% | $81.76 | — | — | CL A | 75615P103 |
| — | AMARIN CORP PLC | 3,312,700 | $53.9M | 0.3% | $16.27 | — | — | SPONS ADR NEW | 023111206 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 4,725,000 | $53.16M | 0.3% | $11.25 | — | — | COM | 462260100 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 1,370,000 | $52.06M | 0.3% | $38.00 | — | — | COM | 37890U108 |
| CRSP | CRISPR THERAPEUTICS AG | 1,018,594 | $45.17M | 0.3% | $44.35 | — | — | NAMEN AKT | H17182108 |
| — | MIRATI THERAPEUTICS INC | 875,000 | $41.21M | 0.2% | $47.10 | — | — | COM | 60468T105 |
| GRFS | GRIFOLS S A | 1,790,000 | $38.25M | 0.2% | $21.37 | — | — | SP ADR REP B NVT | 398438408 |
| — | SUTHERLAND ASSET MGMT CORP M | 2,203,239 | $36.68M | 0.2% | $16.65 | — | — | COM | 86933G105 |
| — | RADIUS HEALTH INC | 2,043,149 | $36.37M | 0.2% | $17.80 | — | — | COM NEW | 750469207 |
| SRPT | SAREPTA THERAPEUTICS INC | 195,000 | $31.49M | 0.2% | $161.51 | — | — | COM | 803607100 |
| — | INTEGRATED DEVICE TECHNOLOGY | 640,000 | $30.09M | 0.2% | $47.01 | — | — | COM | 458118106 |
| SVRA | SAVARA INC | 2,418,009 | $26.98M | 0.2% | $11.16 | — | — | COM | 805111101 |
| BUD | ANHEUSER BUSCH INBEV SA/NV | 293,109 | $25.67M | 0.2% | $87.57 | — | — | SPONSORED ADR | 03524A108 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 276,551 | $24.2M | 0.1% | $87.52 | — | — | COM | 02043Q107 |
| — | AVROBIO INC | 465,000 | $24.12M | 0.1% | $51.87 | — | — | COM | 05455M100 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 2,243,202 | $23.08M | 0.1% | $10.29 | — | — | COM | 74366E102 |
| — | PROGENICS PHARMACEUTICALS IN | 3,612,820 | $22.65M | 0.1% | $6.27 | — | — | COM | 743187106 |
| — | PTC THERAPEUTICS INC | 18,350,000 | $21.11M | 0.1% | $1.15 | — | — | NOTE 3.000% 8/1 | 69366JAB7 |
| — | ZYMEWORKS INC | 1,335,000 | $20.96M | 0.1% | $15.70 | — | — | COM | 98985W102 |
| PTCT | PTC THERAPEUTICS INC | 420,000 | $19.74M | 0.1% | $47.00 | — | — | COM | 69366J200 |
| — | APTINYX INC | 670,000 | $19.4M | 0.1% | $28.96 | — | — | COM | 03836N103 |
| EXEL | EXELIXIS INC | 1,080,000 | $19.14M | 0.1% | $17.72 | — | — | COM | 30161Q104 |
| — | ZAFGEN INC | 1,625,000 | $19M | 0.1% | $11.69 | — | — | COM | 98885E103 |
| PBYI | PUMA BIOTECHNOLOGY INC | 410,000 | $18.8M | 0.1% | $45.85 | — | — | COM | 74587V107 |
| VYGR | VOYAGER THERAPEUTICS INC | 909,158 | $17.2M | 0.1% | $18.92 | — | — | COM | 92915B106 |
| CDXS | CODEXIS INC | 1,000,000 | $17.15M | 0.1% | $17.15 | — | — | COM | 192005106 |
| — | BROOKFIELD PPTY PARTNERS L P | 794,382 | $16.59M | 0.1% | $20.89 | — | — | UNIT LTD PARTN | G16249107 |
| — | SHIRE PLC | 87,000 | $15.77M | 0.1% | $181.26 | — | — | SPONSORED ADR | 82481R106 |
| NTLA | INTELLIA THERAPEUTICS INC | 550,000 | $15.74M | 0.1% | $28.62 | — | — | COM | 45826J105 |
| — | ZEALAND PHARMA A S | 900,000 | $14.87M | 0.1% | $16.52 | — | — | SPONSORED ADR | 98920Y304 |
| — | CHEMOCENTRYX INC | 1,150,000 | $14.54M | 0.1% | $12.64 | — | — | COM | 16383L106 |
| — | SOLID BIOSCIENCES INC | 295,000 | $13.92M | 0.1% | $47.18 | — | — | COM | 83422E105 |
| — | ORBOTECH LTD | 230,000 | $13.67M | 0.1% | $59.44 | — | — | ORD | M75253100 |
| — | DYNAVAX TECHNOLOGIES CORP | 1,070,000 | $13.27M | 0.1% | $12.40 | — | — | COM NEW | 268158201 |
| — | BELLICUM PHARMACEUTICALS INC | 2,136,629 | $13.16M | 0.1% | $6.16 | — | — | COM | 079481107 |
| CHRS | COHERUS BIOSCIENCES INC | 700,000 | $11.55M | 0.1% | $16.50 | — | — | COM | 19249H103 |
| — | ASSEMBLY BIOSCIENCES INC | 300,000 | $11.14M | 0.1% | $37.14 | — | — | COM | 045396108 |
| — | BEMIS INC | 206,660 | $10.04M | 0.1% | $48.60 | — | — | COM | 081437105 |
| VOYA | VOYA FINL INC | 185,000 | $9.189M | 0.1% | $49.67 | — | — | COM | 929089100 |
| FATE | FATE THERAPEUTICS INC | 530,000 | $8.634M | 0.1% | $16.29 | — | — | COM | 31189P102 |
| — | ENDOCYTE INC | 400,000 | $7.104M | 0.0% | $17.76 | — | — | COM | 29269A102 |
| — | INTRA CELLULAR THERAPIES INC | 250,000 | $5.425M | 0.0% | $21.70 | — | — | COM | 46116X101 |
| — | SOLARCITY CORP | 5,000,000 | $4.932M | 0.0% | $0.99 | — | — | NOTE 2.750%11/0 | 83416TAA8 |
| — | TRANSLATE BIO INC | 450,000 | $4.5M | 0.0% | $10.00 | — | — | COM | 89374L104 |
| KALV | KALVISTA PHARMACEUTICALS INC | 200,000 | $4.422M | 0.0% | $22.11 | — | — | COM | 483497103 |
| — | SPECTRUM PHARMACEUTICALS INC | 250,000 | $4.2M | 0.0% | $16.80 | — | — | COM | 84763A108 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 141,815 | $4.063M | 0.0% | $28.65 | — | — | COM | 22663K107 |
| — | SANOFI | 6,827,805 | $3.823M | 0.0% | $0.56 | — | — | RIGHT 12/31/2020 | 80105N113 |
| — | PRINCIPIA BIOPHARMA INC | 125,000 | $3.653M | 0.0% | $29.22 | — | — | COM | 74257L108 |
| — | Y MABS THERAPEUTICS INC | 125,000 | $3.32M | 0.0% | $26.56 | — | — | COM | 984241109 |
| — | PFENEX INC | 600,000 | $3.066M | 0.0% | $5.11 | — | — | COM | 717071104 |
| — | ARQULE INC | 500,000 | $2.83M | 0.0% | $5.66 | — | — | COM | 04269E107 |
| — | RA MED SYS INC | 150,000 | $2.73M | 0.0% | $18.20 | — | — | COM | 74933X104 |
| — | SUTRO BIOPHARMA INC | 150,000 | $2.25M | 0.0% | $15.00 | — | — | COM | 869367102 |
| — | TYME TECHNOLOGIES INC | 405,857 | $1.128M | 0.0% | $2.78 | — | — | COM | 90238J103 |
| — | AKORN INC | 70,000 | $909K | 0.0% | $12.99 | — | — | COM | 009728106 |